Your browser doesn't support javascript.
loading
Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.
Alousi, Amin; Wang, Tao; Hemmer, Michael T; Spellman, Stephen R; Arora, Mukta; Couriel, Daniel R; Pidala, Joseph; Anderlini, Paolo; Boyiadzis, Michael; Bredeson, Christopher N; Cahn, Jean-Yves; Cairo, Mitchell S; Gadalla, Shahinaz M; Hashmi, Shahrukh K; Gale, Robert Peter; Kanda, Junya; Kamble, Rammurti T; Kharfan-Dabaja, Mohamed A; Litzow, Mark R; Ringden, Olle; Saad, Ayman A; Schultz, Kirk R; Verdonck, Leo F; Waller, Edmund K; Yared, Jean A; Holtan, Shernan G; Weisdorf, Daniel J.
Affiliation
  • Alousi A; Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address: aalousi@mdanderson.org.
  • Wang T; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Hemmer MT; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Spellman SR; Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, Minnesota.
  • Arora M; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota.
  • Couriel DR; Utah Blood and Marrow Transplant Program, Salt Lake City, Utah.
  • Pidala J; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Anderlini P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.
  • Boyiadzis M; Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Bredeson CN; The Ottawa Hospital Blood and Marrow Transplant Program and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Cahn JY; Department of Hematology, University Hospital, Grenoble, France.
  • Cairo MS; Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, New York.
  • Gadalla SM; Division of Cancer Epidemiology and Genetics, Clinical Genetics Branch, National Cancer Institute, Rockville, Maryland.
  • Hashmi SK; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Gale RP; Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom.
  • Kanda J; Department of Hematology and Oncology, Jichi Medical University Hospital, Kyoto University, Saitama, Japan.
  • Kamble RT; Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.
  • Kharfan-Dabaja MA; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
  • Litzow MR; Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, Minnesota.
  • Ringden O; Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
  • Saad AA; Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Schultz KR; Department of Pediatric Hematology, Oncology and Bone Marrow Transplant, British Columbia's Children's Hospital, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Verdonck LF; Department of Hematology/Oncology, Isala Clinic, Zwolle, The Netherlands.
  • Waller EK; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Yared JA; Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland.
  • Holtan SG; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota.
  • Weisdorf DJ; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota.
Biol Blood Marrow Transplant ; 25(2): 270-278, 2019 02.
Article in En | MEDLINE | ID: mdl-30292009
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow Transplantation / Hematologic Neoplasms / Peripheral Blood Stem Cell Transplantation / Unrelated Donors / Graft vs Host Disease Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow Transplantation / Hematologic Neoplasms / Peripheral Blood Stem Cell Transplantation / Unrelated Donors / Graft vs Host Disease Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2019 Type: Article